Top Posts

Nour Arida during Paris Fashion Week striking Pink...

DCT Abu Dhabi and New York Knicks Unveil...

Zayed Sustainability Prize Announces 2026 Finalists Driving Global...

LG launches 4K surgical monitor with intelligent features...

TransformED 2025 Summit at AUB Explores New Pathways...

Ministry of Culture collaborates with Google Arts &...

MAISON RAMI KADI UNVEILS “BLOOMING UNIVERSE” AT DIANA...

LG reaffirms universal value of life through AI...

SILVERCAT BREAKS NEW GROUND WITH FIRST CRYPTOCURRENCY SALE...

TAWFEER MAX LAUNCHES IN LEBANON

Finance
Business
Tourism & Hospitality
Lifestyle & Health
Science & Technology
Humanitarian
Culture and Arts
News
PR Agency

Home Tags Posts tagged with "Empagliflozin"

Tag:

Empagliflozin

Lifestyle & Health slider
Landmark trial, EMPEROR-Preserved, demonstrates empagliflozin is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction

by Karine Ayoub November 2, 2021

by Karine Ayoub November 2, 2021

In this clinical study for adults with heart failure with preserved ejection fraction, empagliflozin …

0 Facebook Twitter Pinterest Email

Weekly Notification

Bulletin’s Archive

Bulletin’s Archive

Search Bulletins

Tags

Abu Dhabi Ports American University of Beirut American University of Sharjah (AUS) AUB aubmc Bank Audi Blom Bank Breitling Byblos Bank cannes lions Corona Virus (COVID-19) COVID-19 Corona Elie Saab Emirates Ericsson Garena Free Fire Gartner Global Village Globemed Grohe Huawei Hyundai Kandima Maldives Kia Kia Corporation LAU Medical Center Rizk Hospital LG LG Electronics Maserati Mastercard NISSAN PRCA MENA Ralph & Russo Ramadan Rebirth Beirut Salesforce Samsung SAP Starzplay Tony Ward UN UNICEF United Nations VFS Global Zuhair Murad

THE BULLETIN

All press releases and company news, brochures, logos, videos, images, and brands are property of their respective owners and not the bulletin.
All press releases and company news, brochures, logos, videos, images, and brands references used in this website are for identification and informational purposes only.
Use of these press releases and company news, brochures, logos, videos, images, and brands does not imply endorsement by, sponsorship by, or affiliation with the bulletin.

JOIN US

About us
Contact us
HOME

Keep in touch

Facebook

@2024 - All Right Reserved.

Finance
Business
Tourism & Hospitality
Lifestyle & Health
Science & Technology
Humanitarian
Culture and Arts
News
PR Agency